文献速递肾小球疾病慢性肾脏病

病毒相关性肾小球肾炎:丙型肝炎与HIV

Viral-Associated GN: Hepatitis C and HIV.
PubMed 文献 · Clin J Am Soc Nephrol · 2016-10-24

综述丙型肝炎(HCV)与HIV相关肾小球疾病的机制、流行病学与诊治;约25%-30%的HIV患者合并HCV,5%-10%的HCV患者合并HIV;两者均依赖病毒活跃复制致病,应归为感染相关性肾小球肾炎而非感染后肾小球肾炎;早期启动直接抗病毒药物或联合抗逆转录病毒治疗可实现缓解甚至病变消退。

要点

  • HCV与HIV相关肾小球疾病均依赖病毒活跃复制,应归为感染相关性肾小球肾炎而非感染后肾小球肾炎。
  • 约25%-30%的HIV患者合并HCV,5%-10%的HCV患者合并HIV,双重感染时肾小球疾病鉴别诊断困难。
  • 早期启动HCV直接抗病毒药物或HIV联合抗逆转录病毒治疗,可实现肾小球病变缓解甚至消退。

核心结论

  • HCV与HIV相关肾小球疾病均依赖病毒活跃复制,应归为感染相关性肾小球肾炎而非感染后肾小球肾炎。
  • 早期启动直接抗病毒药物或联合抗逆转录病毒治疗可实现肾小球病变缓解甚至消退。

研究设计与样本

  • 综述,阐述病毒相关肾小球疾病的机制、流行病学与诊治。

主要发现

  • 约25%-30%的HIV患者合并HCV,5%-10%的HCV患者合并HIV。
  • 病毒可直接感染肾组织,病毒抗原形成的循环免疫复合物可沉积于肾小球基底膜。
  • HCV与HIV相关肾小球疾病均依赖病毒活跃复制,病毒血症控制且不活跃后不引起肾损伤。

关键数值与推荐

  • 约25%-30%的HIV患者合并HCV,5%-10%的HCV患者合并HIV。

临床怎么用

  • 临床医生需熟悉HCV与HIV相关肾病的临床表现、实验室检查和病理生理,以应对双重感染人群的鉴别诊断。
  • 早期启动HCV直接抗病毒药物或HIV联合抗逆转录病毒治疗可实现肾小球病变缓解甚至消退。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Viruses are capable of inducing a wide spectrum of glomerular disorders that can be categorized on the basis of the duration of active viremia: acute, subacute, or chronic. The variable responses of the adaptive immune system to each time period of viral infection results mechanistically in different histologic forms of glomerular injury. The unique presence of a chronic viremic carrier state with either hepatitis C (HCV) or HIV has led to the opportunity to study in detail various pathogenic mechanisms of viral-induced glomerular injury, including direct viral infection of renal tissue and the development of circulating immune complexes composed of viral antigens that deposit along the glomerular basement membrane. Epidemiologic data show that approximately 25%-30% of all HIV patients are coinfected with HCV and 5%-10% of all HCV patients are coinfected with HIV. This situation can often lead to a challenging differential diagnosis when glomerular disease occurs in this dual-infected population and requires the clinician to be familiar with the clinical presentation, laboratory workup, and pathophysiology behind the development of renal disease for both HCV and HIV. Both of these viruses can be categorized under the new classification of infection-associated GN as opposed to being listed as causes of postinfectious GN as has previously been applied to them. Neither of these viruses lead to renal injury after a latent period of controlled and inactive viremia. The geneses of HCV- and HIV-associated glomerular diseases share a total dependence on the presence of active viral replication to sustain renal injury so the renal disease cannot be listed under "postinfectious" GN. With the new availability of direct-acting antivirals for HCV and more effective combined antiretroviral therapy for HIV, successful remission and even regression of glomerular lesions can be achieved if initiated at an early stage.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kupin WL. Viral-Associated GN: Hepatitis C and HIV. Clin J Am Soc Nephrol. 2016. PMID: 27797895. doi:10.2215/CJN.04320416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。